Human POLE Gene Mutation Detection Test Kit

qPCR-based kit for detection of 6 POLE mutations in solid tumors. Provides cost-effective POLE mutation analysis on standard real-time PCR systems.

Comprehensive analysis kit for detection of 19 defined mutations within POLE and POLD1 genes. Identifies polymerase-associated mutations relevant to tumor biology and treatment response.

Diagnostic kit using PCR methodology for identifying genetic mutations and polymorphisms. Supports clinical diagnosis of genetic disorders and carrier screening.

Molecular diagnostic kit for identification of specific genetic mutations associated with disease or resistance. Enables targeted diagnostic and therapeutic decision-making.

A diagnostic kit based on GENETRON's proprietary 'one-step method' technology enabling completion of library construction in 1.5 to 3 hours (China patent ZL 201710218529.4). It detects EGFR, KRAS, BRAF, HER2, and PIK3CA gene mutations in DNA and ALK and ROS1 gene fusions in RNA from FFPE tissue samples of non-small cell lung cancer patients, as well as MET gene 14 exon skipping mutations.

A diagnostic kit developed using gene detection technology and molecular biology methods for genomic analysis. Applicable in disease screening and diagnostic evaluation across clinical laboratory settings.

CE IVD real-time PCR kit for detection of APOB R3500Q mutation in human genomic DNA. Supports diagnosis of familial defective apolipoprotein B-100 and lipid disorder assessment.

Diagnostic test kit for identification of genetic mutations and inherited disorders through nucleic acid sequencing. Supports clinical genetic testing and carrier screening applications.

In vitro diagnostic kit for detecting gene polymorphisms associated with neural tube defects through molecular analysis. Enables risk assessment and genetic screening in prenatal and family planning contexts. Supports personalized medicine approaches for birth defect prevention.

A diagnostic test kit designed to detect mutations associated with colorectal cancer. This panel enables identification of genetic alterations relevant to colorectal cancer diagnosis and management.

Diagnostic kit for detecting relevant mutations in colorectal cancer tissue samples. Identifies mutations affecting prognosis and treatment selection.

PCR-based molecular diagnostic kit for genetic disease detection and identification. Utilizes polymerase chain reaction technology for accurate nucleic acid analysis.